As of January 2025, GeneMatrix has a market cap of $32.97M. This makes GeneMatrix the world's 25383th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $32.60M | -13.69% |
2023 | $37.77M | -24.27% |
2022 | $49.87M | -58.16% |
2021 | $119.21M | 86.31% |
2018 | $63.98M | 47.55% |
2017 | $43.37M | -30.23% |
2016 | $62.16M | 58.20% |
2015 | $39.29M | 30.24% |
2014 | $30.17M | 41.31% |
2013 | $21.35M | -50.49% |
2012 | $43.12M | - |